Enhancement of potency and efficacy of NADA by PKC-mediated phosphorylation of vanilloid receptor

J Neurophysiol. 2004 Mar;91(3):1442-9. doi: 10.1152/jn.00745.2003.

Abstract

The search for an endogenous ligand for the vanilloid receptor (VR or TRPV1) has led to the identification of N-arachidonyl dopamine (NADA). This study investigates the role of protein kinase C (PKC)-mediated phosphorylation on NADA-induced membrane currents in Xenopus oocytes heterologously expressing TRPV1 and in dorsal root ganglion (DRG) neurons. In basal state, current induced by 10 microM NADA is 5-10% of the current induced by 1 microM capsaicin or protons at pH 5. However, PKC activator, phorbol 12,13-dibutyrate (PDBu) strongly potentiated ( approximately 15-fold) the NADA-induced current. Repeated application of NADA at short intervals potentiated its own response approximately fivefold in a PKC-dependent manner. PKC inhibitor, bisindolylmaleimide (BIM, 500 nM), a mutant TRPV1 (S800A/S502A), and maximal activation of PKC abolished the potentiation induced by repeated application of NADA. As a further confirmation that NADA could stimulate PKC, pretreatment with NADA potentiated the response of protons at pH 5 (approximately 20 fold), which was dramatically reduced in the mutant TRPV1. In DRG neurons, capsaicin (100 nM) induced a approximately 15 mV depolarization and initiated a train of action potentials compared with 1 microM NADA that produced a approximately 5 mV response. Pretreatment with PDBu induced significantly larger depolarization and potentiated NADA-induced current. Furthermore, exposure of NADA to the intracellular surface of the membrane-induced larger currents suggesting inaccessibility to the intracellular binding site might contribute to its weaker action. These results indicate that NADA is a potent agonist of VR when the receptor is in the PKC-mediated phosphorylation state.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Action Potentials / physiology
  • Animals
  • Arachidonic Acids / pharmacology*
  • Dopamine / analogs & derivatives*
  • Dopamine / pharmacology*
  • Electrophysiology
  • Female
  • Ganglia, Spinal / cytology
  • Ganglia, Spinal / drug effects
  • Lipids / physiology
  • Membrane Potentials / physiology
  • Microinjections
  • Oocytes / drug effects
  • Oocytes / physiology
  • Patch-Clamp Techniques
  • Phorbol 12,13-Dibutyrate / pharmacology
  • Phosphorylation
  • Pregnancy
  • Protein Kinase C / drug effects*
  • Protons
  • Rats
  • Receptors, Drug / drug effects*
  • Receptors, Drug / metabolism
  • Xenopus laevis

Substances

  • Arachidonic Acids
  • Lipids
  • Protons
  • Receptors, Drug
  • arachidonyl dopamine
  • Phorbol 12,13-Dibutyrate
  • Protein Kinase C
  • Dopamine